Arkema S.A. Logo

Arkema S.A.

ARKAY

(2.8)
Stock Price

77,92 USD

3.72% ROA

4.96% ROE

18.28x PER

Market Cap.

6.543.287.391,38 USD

79.29% DER

4.26% Yield

3.8% NPM

Arkema S.A. Stock Analysis

Arkema S.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Arkema S.A. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.98x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROE

ROE in an average range (7.03%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (5.94%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 DER

The stock has a reasonable amount of debt compared to its ownership (51%), suggesting a balanced financial position and a moderate level of risk.

6 Assets Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

7 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

8 Dividend Growth

Investors can take confidence in the company's impressive track record of annual dividend growth over the last three years, showcasing a commitment to providing higher returns.

9 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (2.962) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

11 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

Arkema S.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Arkema S.A. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Arkema S.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Arkema S.A. Revenue
Year Revenue Growth
2004 5.318.000.000
2005 5.515.000.000 3.57%
2006 5.664.000.000 2.63%
2007 5.675.000.000 0.19%
2008 5.633.000.000 -0.75%
2009 4.444.000.000 -26.76%
2010 5.905.000.000 24.74%
2011 5.900.000.000 -0.08%
2012 6.395.000.000 7.74%
2013 6.098.000.000 -4.87%
2014 5.952.000.000 -2.45%
2015 7.683.000.000 22.53%
2016 7.535.000.000 -1.96%
2017 8.326.000.000 9.5%
2018 8.816.000.000 5.56%
2019 8.738.000.000 -0.89%
2020 7.884.000.000 -10.83%
2021 9.519.000.000 17.18%
2022 11.550.000.000 17.58%
2023 9.304.000.000 -24.14%
2023 9.514.000.000 2.21%
2024 10.144.000.000 6.21%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Arkema S.A. Research and Development Expenses
Year Research and Development Expenses Growth
2004 183.000.000
2005 176.000.000 -3.98%
2006 168.000.000 -4.76%
2007 158.000.000 -6.33%
2008 150.000.000 -5.33%
2009 136.000.000 -10.29%
2010 139.000.000 2.16%
2011 132.000.000 -5.3%
2012 148.000.000 10.81%
2013 144.000.000 -2.78%
2014 155.000.000 7.1%
2015 209.000.000 25.84%
2016 222.000.000 5.86%
2017 235.000.000 5.53%
2018 237.000.000 0.84%
2019 249.000.000 4.82%
2020 241.000.000 -3.32%
2021 243.000.000 0.82%
2022 270.000.000 10%
2023 272.000.000 0.74%
2023 275.000.000 1.09%
2024 272.000.000 -1.1%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Arkema S.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 420.000.000
2005 431.000.000 2.55%
2006 417.000.000 -3.36%
2007 397.000.000 -5.04%
2008 393.000.000 -1.02%
2009 357.000.000 -10.08%
2010 387.000.000 7.75%
2011 374.000.000 -3.48%
2012 432.000.000 13.43%
2013 416.000.000 -3.85%
2014 424.000.000 1.89%
2015 664.000.000 36.14%
2016 691.000.000 3.91%
2017 727.000.000 4.95%
2018 747.000.000 2.68%
2019 773.000.000 3.36%
2020 745.000.000 -3.76%
2021 784.000.000 4.97%
2022 868.000.000 9.68%
2023 836.000.000 -3.83%
2023 874.000.000 4.35%
2024 952.000.000 8.19%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Arkema S.A. EBITDA
Year EBITDA Growth
2004 -545.000.000
2005 -149.000.000 -265.77%
2006 319.000.000 146.71%
2007 467.000.000 31.69%
2008 473.000.000 1.27%
2009 242.000.000 -95.45%
2010 762.000.000 68.24%
2011 1.309.000.000 41.79%
2012 1.033.000.000 -26.72%
2013 904.000.000 -14.27%
2014 781.000.000 -15.75%
2015 1.109.000.000 29.58%
2016 1.285.000.000 13.7%
2017 1.388.000.000 7.42%
2018 1.494.000.000 7.1%
2019 1.508.000.000 0.93%
2020 1.222.000.000 -23.4%
2021 1.867.000.000 34.55%
2022 2.120.000.000 11.93%
2023 1.568.000.000 -35.2%
2023 1.435.000.000 -9.27%
2024 1.804.000.000 20.45%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Arkema S.A. Gross Profit
Year Gross Profit Growth
2004 4.110.000.000
2005 4.412.000.000 6.84%
2006 4.987.000.000 11.53%
2007 5.048.000.000 1.21%
2008 793.000.000 -536.57%
2009 533.000.000 -48.78%
2010 1.029.000.000 48.2%
2011 1.268.000.000 18.85%
2012 1.258.000.000 -0.79%
2013 1.148.000.000 -9.58%
2014 1.026.000.000 -11.89%
2015 1.477.000.000 30.53%
2016 1.647.000.000 10.32%
2017 1.859.000.000 11.4%
2018 1.975.000.000 5.87%
2019 1.901.000.000 -3.89%
2020 1.548.000.000 -22.8%
2021 2.143.000.000 27.76%
2022 2.580.000.000 16.94%
2023 9.304.000.000 72.27%
2023 1.960.000.000 -374.69%
2024 2.284.000.000 14.19%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Arkema S.A. Net Profit
Year Net Profit Growth
2004 -581.000.000
2005 -428.000.000 -35.75%
2006 47.000.000 1010.64%
2007 122.000.000 61.48%
2008 100.000.000 -22%
2009 -172.000.000 158.14%
2010 347.000.000 149.57%
2011 -19.000.000 1926.32%
2012 220.000.000 108.64%
2013 168.000.000 -30.95%
2014 167.000.000 -0.6%
2015 285.000.000 41.4%
2016 394.000.000 27.66%
2017 543.000.000 27.44%
2018 674.000.000 19.44%
2019 491.000.000 -37.27%
2020 332.000.000 -47.89%
2021 1.309.000.000 74.64%
2022 965.000.000 -35.65%
2023 456.000.000 -111.62%
2023 418.000.000 -9.09%
2024 580.000.000 27.93%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Arkema S.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 -9
2005 -7 -50%
2006 1 0%
2007 2 100%
2008 2 0%
2009 -3 150%
2010 5 140%
2011 0 0%
2012 3 100%
2013 3 -50%
2014 3 0%
2015 4 33.33%
2016 5 40%
2017 7 28.57%
2018 9 12.5%
2019 6 -33.33%
2020 4 -100%
2021 17 82.35%
2022 13 -41.67%
2023 6 -140%
2023 5 0%
2024 8 28.57%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Arkema S.A. Free Cashflow
Year Free Cashflow Growth
2004 -266.000.000
2005 -385.000.000 30.91%
2006 -274.000.000 -40.51%
2007 -6.000.000 -4466.67%
2008 -18.000.000 66.67%
2009 105.000.000 117.14%
2010 196.000.000 46.43%
2011 -461.000.000 142.52%
2012 15.000.000 3173.33%
2013 -14.000.000 207.14%
2014 21.000.000 166.67%
2015 365.000.000 94.25%
2016 339.000.000 -7.67%
2017 549.000.000 38.25%
2018 438.000.000 -25.34%
2019 639.000.000 31.46%
2020 510.000.000 -25.29%
2021 152.000.000 -235.53%
2022 766.000.000 80.16%
2023 593.000.000 -29.17%
2023 120.000.000 -394.17%
2024 144.000.000 16.67%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Arkema S.A. Operating Cashflow
Year Operating Cashflow Growth
2004 34.000.000
2005 -46.000.000 173.91%
2006 68.000.000 167.65%
2007 319.000.000 78.68%
2008 331.000.000 3.63%
2009 452.000.000 26.77%
2010 511.000.000 11.55%
2011 543.000.000 5.89%
2012 499.000.000 -8.82%
2013 467.000.000 -6.85%
2014 507.000.000 7.89%
2015 858.000.000 40.91%
2016 821.000.000 -4.51%
2017 1.008.000.000 18.55%
2018 1.029.000.000 2.04%
2019 1.300.000.000 20.85%
2020 1.115.000.000 -16.59%
2021 915.000.000 -21.86%
2022 1.496.000.000 38.84%
2023 1.272.000.000 -17.61%
2023 393.000.000 -223.66%
2024 295.000.000 -33.22%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Arkema S.A. Capital Expenditure
Year Capital Expenditure Growth
2004 300.000.000
2005 339.000.000 11.5%
2006 342.000.000 0.88%
2007 325.000.000 -5.23%
2008 349.000.000 6.88%
2009 347.000.000 -0.58%
2010 315.000.000 -10.16%
2011 1.004.000.000 68.63%
2012 484.000.000 -107.44%
2013 481.000.000 -0.62%
2014 486.000.000 1.03%
2015 493.000.000 1.42%
2016 482.000.000 -2.28%
2017 459.000.000 -5.01%
2018 591.000.000 22.34%
2019 661.000.000 10.59%
2020 605.000.000 -9.26%
2021 763.000.000 20.71%
2022 730.000.000 -4.52%
2023 679.000.000 -7.51%
2023 273.000.000 -148.72%
2024 151.000.000 -80.79%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Arkema S.A. Equity
Year Equity Growth
2004 1.717.000.000
2005 1.463.000.000 -17.36%
2006 1.938.000.000 24.51%
2007 1.935.000.000 -0.16%
2008 2.018.000.000 4.11%
2009 1.813.000.000 -11.31%
2010 2.240.000.000 19.06%
2011 2.217.000.000 -1.04%
2012 2.311.000.000 4.07%
2013 2.349.000.000 1.62%
2014 3.573.000.000 34.26%
2015 3.949.000.000 9.52%
2016 4.249.000.000 7.06%
2017 4.474.000.000 5.03%
2018 5.028.000.000 11.02%
2019 5.324.000.000 5.56%
2020 5.235.000.000 -1.7%
2021 6.350.000.000 17.56%
2022 7.339.000.000 13.48%
2023 7.391.000.000 0.7%
2023 7.455.000.000 0.86%
2024 6.804.000.000 -9.57%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Arkema S.A. Assets
Year Assets Growth
2004 4.455.000.000
2005 4.664.000.000 4.48%
2006 4.541.000.000 -2.71%
2007 4.436.000.000 -2.37%
2008 4.473.000.000 0.83%
2009 3.945.000.000 -13.38%
2010 4.818.000.000 18.12%
2011 5.332.000.000 9.64%
2012 5.541.000.000 3.77%
2013 5.476.000.000 -1.19%
2014 6.814.000.000 19.64%
2015 8.721.000.000 21.87%
2016 9.050.000.000 3.64%
2017 9.576.000.000 5.49%
2018 10.111.000.000 5.29%
2019 10.977.000.000 7.89%
2020 10.711.000.000 -2.48%
2021 12.301.000.000 12.93%
2022 13.511.000.000 8.96%
2023 13.667.000.000 1.14%
2023 14.517.000.000 5.86%
2024 15.091.000.000 3.8%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Arkema S.A. Liabilities
Year Liabilities Growth
2004 2.738.000.000
2005 3.201.000.000 14.46%
2006 2.603.000.000 -22.97%
2007 2.501.000.000 -4.08%
2008 2.455.000.000 -1.87%
2009 2.132.000.000 -15.15%
2010 2.578.000.000 17.3%
2011 3.115.000.000 17.24%
2012 3.230.000.000 3.56%
2013 3.127.000.000 -3.29%
2014 3.241.000.000 3.52%
2015 4.772.000.000 32.08%
2016 4.801.000.000 0.6%
2017 5.102.000.000 5.9%
2018 5.083.000.000 -0.37%
2019 5.653.000.000 10.08%
2020 5.476.000.000 -3.23%
2021 5.951.000.000 7.98%
2022 6.172.000.000 3.58%
2023 6.276.000.000 1.66%
2023 7.062.000.000 11.13%
2024 8.287.000.000 14.78%

Arkema S.A. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
126.21
Net Income per Share
4.79
Price to Earning Ratio
18.28x
Price To Sales Ratio
0.69x
POCF Ratio
5.3
PFCF Ratio
14.26
Price to Book Ratio
1
EV to Sales
1.04
EV Over EBITDA
7.24
EV to Operating CashFlow
7.95
EV to FreeCashFlow
21.38
Earnings Yield
0.05
FreeCashFlow Yield
0.07
Market Cap
6,54 Bil.
Enterprise Value
9,81 Bil.
Graham Number
97.33
Graham NetNet
-56.84

Income Statement Metrics

Net Income per Share
4.79
Income Quality
3.38
ROE
0.05
Return On Assets
0.02
Return On Capital Employed
0.05
Net Income per EBT
0.66
EBT Per Ebit
0.82
Ebit per Revenue
0.07
Effective Tax Rate
0.32

Margins

Sales, General, & Administrative to Revenue
0.09
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.21
Operating Profit Margin
0.07
Pretax Profit Margin
0.06
Net Profit Margin
0.04

Dividends

Dividend Yield
0.04
Dividend Yield %
4.26
Payout Ratio
0.77
Dividend Per Share
3.74

Operating Metrics

Operating Cashflow per Share
16.54
Free CashFlow per Share
6.15
Capex to Operating CashFlow
0.63
Capex to Revenue
0.08
Capex to Depreciation
1.03
Return on Invested Capital
0.04
Return on Tangible Assets
0.04
Days Sales Outstanding
64.83
Days Payables Outstanding
54.43
Days of Inventory on Hand
66.5
Receivables Turnover
5.63
Payables Turnover
6.71
Inventory Turnover
5.49
Capex per Share
10.39

Balance Sheet

Cash per Share
28,20
Book Value per Share
91,11
Tangible Book Value per Share
17.98
Shareholders Equity per Share
87.82
Interest Debt per Share
70.3
Debt to Equity
0.79
Debt to Assets
0.34
Net Debt to EBITDA
2.41
Current Ratio
1.86
Tangible Asset Value
1,34 Bil.
Net Current Asset Value
-2,96 Bil.
Invested Capital
11709000000
Working Capital
2,46 Bil.
Intangibles to Total Assets
0.36
Average Receivables
1,73 Bil.
Average Payables
1,09 Bil.
Average Inventory
1343500000
Debt to Market Cap
0.79

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Arkema S.A. Dividends
Year Dividends Growth
2008 1
2009 1 0%
2010 1 0%
2011 1 100%
2012 2 0%
2013 2 50%
2014 5 50%
2015 2 -100%
2016 2 0%
2017 2 0%
2018 3 0%
2019 3 0%
2020 2 0%
2021 3 0%
2022 3 33.33%
2023 4 0%
2024 4 0%

Arkema S.A. Profile

About Arkema S.A.

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. The company also offers advanced materials consisting of specialty polyamides and polyvinylidene fluoride; and performance additives, such as specialty surfactants and molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide for use in automotive and transportation, oil and gas, renewable energies, consumer goods, electronics, construction, coatings, animal nutrition, and water treatment sectors. In addition, it provides coating solutions comprising EU/US acrylics and coating resins; sartomer photocure resins and coatex rheology additives; decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbents, water treatment and oil and gas extraction, and 3D printing and electronics industries. Further, the company offers fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.

CEO
Mr. Thierry Le Henaff
Employee
20.946
Address
420 rue d'Estienne d'Orves
Colombes, 92700

Arkema S.A. Executives & BODs

Arkema S.A. Executives & BODs
# Name Age
1 Mr. Marc Schuller
Chief Operating Officer of Coating Solutions, Intermediates & Advanced Materials
70
2 Mr. Thierry Parmentier
Executive Vice President of Human Resources & Corporate Communication
70
3 Mr. Richard Jenkins
Senior Vice President of Coating Solutions
70
4 Mr. Christophe Villain
Executive Vice-President of Advanced Materials
70
5 Mr. Luc Benoit-Cattin
Executive Vice President of Industry & CSR
70
6 Ms. Marie-José Donsion
Chief Financial Officer
70
7 Mr. Armand Ajdari
Chief Technology Officer
70
8 Mr. Erwoan Pezron
Advisor to the Chairman and Chief Executive Officer
70
9 Mr. Thierry Le Henaff
Chairman & Chief Executive Officer
70
10 Beatrice Zilm
Vice President of Investor Relations
70

Arkema S.A. Competitors

Akzo Nobel N.V. Logo
Akzo Nobel N.V.

AKZOF

(2.0)
Avoca LLC Logo
Avoca LLC

AVOA

(0.0)
AGC Inc. Logo
AGC Inc.

ASGLY

(1.8)